CAS 1191995-00-2

Dorzagliatin

CAS: 1191995-00-2

Dorzagliatin (HMS5552) is a dual-acting glucokinase (GK) activator. It also improves glycaemic control and pancreatic β-cell function in type 2 diabetes.

Fórmula: C₂₂H₂₇ClN₄O₅

Pureza: 98.67% - 99.45%

Forma y color: Solid

Peso molecular: 462.93

Ref: TM-T15159

Dorzagliatin

CAS: 1191995-00-2

Fórmula: C₂₂H₂₇ClN₄O₅

Pureza: 99%

Forma y color: Solid

Peso molecular: 462.9266

Ref: IN-DA01V2UF

(S)-2-(4-(2-Chlorophenoxy)-2-Oxo-2,5-Dihydro-1H-Pyrrol-1-Yl)-N-(1-((R)-2,3-Dihydroxypropyl)-1H-Pyrazol-3-Yl)-4-Methylpentanamide

CAS: 1191995-00-2

(S)-2-(4-(2-Chlorophenoxy)-2-Oxo-2,5-Dihydro-1H-Pyrrol-1-Yl)-N-(1-((R)-2,3-Dihydroxypropyl)-1H-Pyrazol-3-Yl)-4-Methylpentanamide

Pureza: 97%

Peso molecular: 462.93g/mol

Ref: 54-OR1024215

Dorzagliatin

CAS: 1191995-00-2

Dorzagliatin

Pureza: ≥98%

Peso molecular: 462.93g/mol

Ref: 54-BUP12514

Dorzagliatin

CAS: 1191995-00-2

Dorzagliatin is a new drug for the treatment of type 2 diabetes. It has been shown to be effective in diabetic patients, with a long-term efficacy and pharmacokinetic properties. Dorzagliatin has also been shown to have a pharmacological effect on β-cells, which are cells that produce insulin in the pancreas. This drug's activity is due to its ability to inhibit the production of growth factors and plasma concentration–time curve. In addition, dorzagliatin does not have any enantiomeric isomers and can be detected in blood plasma within one hour after administration.

Fórmula: C₂₂H₂₇ClN₄O₅

Pureza: Min. 95%

Peso molecular: 462.93 g/mol

Ref: 3D-BD167920